更正：无活性基质γ-羧基谷氨酸蛋白血浆水平与2型糖尿病周围神经病变相关。 更正：无活性基质γ-羧基谷氨酸蛋白血浆水平与2型糖尿病周围神经病变相关。
Correction: Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.
出版信息
PLoS One. 2021 Mar 4;16(3):e0248441. doi: 10.1371/journal.pone.0248441. eCollection 2021.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0232996.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0232996。]
相似文献
1
Correction: Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.更正：无活性基质γ-羧基谷氨酸蛋白血浆水平与2型糖尿病周围神经病变相关。 更正：无活性基质γ-羧基谷氨酸蛋白血浆水平与2型糖尿病周围神经病变相关。
PLoS One. 2021 Mar 4;16(3):e0248441. doi: 10.1371/journal.pone.0248441. eCollection 2021.
2
Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.更正：无活性基质γ-羧基谷氨酸蛋白血浆水平与2型糖尿病周围神经病变相关。
PLoS One. 2020 May 5;15(5):e0232996. doi: 10.1371/journal.pone.0232996. eCollection 2020.
3
Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.非活性基质 gla 蛋白的血浆水平与 2 型糖尿病周围神经病变有关。
PLoS One. 2020 Feb 24;15(2):e0229145. doi: 10.1371/journal.pone.0229145. eCollection 2020.
4
Correction: Cardiovascular Variability Analysis and Baroreflex Estimation in Patients with Type 2 Diabetes in Absence of Any Manifest Neuropathy.更正：2型糖尿病且无任何明显神经病变患者的心血管变异性分析和压力反射估计
PLoS One. 2017 Mar 16;12(3):e0174492. doi: 10.1371/journal.pone.0174492. eCollection 2017.
5
Correction: Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases.更正：富含γ-羧基谷氨酸蛋白在单核细胞/巨噬细胞中作为抗炎剂的作用：对钙化相关慢性炎症性疾病的影响。
PLoS One. 2018 Feb 8;13(2):e0192875. doi: 10.1371/journal.pone.0192875. eCollection 2018.
6
Correction: PINK1 alleviates thermal hypersensitivity in a paclitaxel-induced Drosophila model of peripheral neuropathy.更正：在紫杉醇诱导的果蝇周围神经病变模型中，PINK1可减轻热超敏反应。
PLoS One. 2021 Sep 10;16(9):e0257439. doi: 10.1371/journal.pone.0257439. eCollection 2021.
7
Correction: Using time series analysis approaches for improved prediction of pain outcomes in subgroups of patients with painful diabetic peripheral neuropathy.更正：使用时间序列分析方法改善对疼痛性糖尿病周围神经病变患者亚组疼痛结局的预测。
PLoS One. 2019 Feb 26;14(2):e0212959. doi: 10.1371/journal.pone.0212959. eCollection 2019.
8
Correction: manual acupuncture for treatment of diabetic peripheral neuropathy: a systematic review of randomized controlled trials.更正：手动针刺治疗糖尿病周围神经病变：随机对照试验的系统评价
PLoS One. 2014 Mar 10;9(3):e91110. doi: 10.1371/journal.pone.0091110. eCollection 2014.
9
Correction: Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus.更正：血浆1-脱氧鞘脂是2型糖尿病发病的早期预测指标。
PLoS One. 2017 Jun 5;12(6):e0179313. doi: 10.1371/journal.pone.0179313. eCollection 2017.
10
Correction: Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.更正：紫杉醇治疗的女性癌症幸存者化疗引起的周围神经病变的危险因素及药物治疗：日本的一项回顾性研究。
PLoS One. 2024 Jul 23;19(7):e0307865. doi: 10.1371/journal.pone.0307865. eCollection 2024.
本文引用的文献
1
Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.更正：无活性基质γ-羧基谷氨酸蛋白血浆水平与2型糖尿病周围神经病变相关。
PLoS One. 2020 May 5;15(5):e0232996. doi: 10.1371/journal.pone.0232996. eCollection 2020.
2
Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.非活性基质 gla 蛋白的血浆水平与 2 型糖尿病周围神经病变有关。
PLoS One. 2020 Feb 24;15(2):e0229145. doi: 10.1371/journal.pone.0229145. eCollection 2020.
Zotero 插件